Cammie Tran
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cammie Tran has a total of 103 co-authors. Here are the top co-authors by number of shared publications:
- John James McNeil
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
9 shared publications - Robyn Lorraine Woods
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
6 shared publications - Joanne Ryan
School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
5 shared publications - Andrew M. Tonkin
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
4 shared publications - Johannes Tobias Neumann
Department of Epidemiology and Preventive Medicine, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
4 shared publications - Mark Raymond Nelson
School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
4 shared publications
Latest Publications
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (8) , e013687
Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE
BACKGROUND: Previous studies showed that the Pooled Cohort Equations substantially overestimate atherosclerotic cardiovascular disease (ASCVD) risk in older adults, and the recently published predicting risk of cardiovascular disease events (PREVENT) equation offers better performance. Identifying markers that can further refine risk estimates is essential for personalized prevention in this age group. This study evaluates the clinical utility of 6 markers for reclassifying intermediate-risk older adults (10-year PREVENT-estimated ASCVD risk, 7.5% to 20%), with a focus on de-escalation. METHODS: This post hoc analysis evaluated intermediate-risk older adults aged ≥70 years using data from ASPREE (Aspirin in Reducing Events in the Elderly; URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583). ASPREE was a randomized trial of low-dose aspirin versus placebo in healthy older adults who were free of prior cardiovascular events at enrollment. Six markers were evaluated: the lowest quartile (Q1) of NT-proBNP (N-terminal pro-B-type natriuretic peptide), hs-TnI (high-sensitivity troponin I), and hs-CRP (high-sensitivity C-reactive protein), polygenic risk for lipoprotein(a) and polygenic risk for coronary artery disease, and absence of family history of ASCVD. Incident ASCVD events were adjudicated by expert panels. Statistical performance of each marker was assessed using diagnostic likelihood ratios, change in Harrell C statistic (ΔC), and net reclassification index relative to a baseline model incorporating variables included in the PREVENT equation. RESULTS: The study included 7764 participants (48% female; median age, 74 years [interquartile range, 72–77]), with a median follow-up of 10.3 years. During follow-up, 725 participants (9.3%) experienced ASCVD events. Q1 polygenic risk for coronary artery disease was the most powerful marker for down-grading risk, providing 37% risk reduction (diagnostic likelihood ratio: 0.627) and improving discrimination (ΔC: +1.44%; P =0.004) when compared with the baseline model, and correctly reclassifying 25.9% of nonevents downward (net reclassification index: 0.101). Q1 hs-TnI showed second-best performance (diagnostic likelihood ratio: 0.727; ΔC: +0.71%, net reclassification index: 0.075). CONCLUSIONS: Adding polygenic risk for coronary artery disease to the PREVENT equations may further personalize risk estimates and support clinical decision-making for older adults at intermediate risk for ASCVD events.
- 1 August 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
- Vol. 19 (8) , e013687
Identifying Risk-De-Escalating Markers in PREVENT-Defined Intermediate-Risk Older Adults: Insights From ASPREE
BACKGROUND: Previous studies showed that the Pooled Cohort Equations substantially overestimate atherosclerotic cardiovascular disease (ASCVD) risk in older adults, and the recently published predicting risk of cardiovascular disease events (PREVENT) equation offers better performance. Identifying markers that can further refine risk estimates is essential for personalized prevention in this age group. This study evaluates the clinical utility of 6 markers for reclassifying intermediate-risk older adults (10-year PREVENT-estimated ASCVD risk, 7.5% to 20%), with a focus on de-escalation. METHODS: This post hoc analysis evaluated intermediate-risk older adults aged ≥70 years using data from ASPREE (Aspirin in Reducing Events in the Elderly; URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583). ASPREE was a randomized trial of low-dose aspirin versus placebo in healthy older adults who were free of prior cardiovascular events at enrollment. Six markers were evaluated: the lowest quartile (Q1) of NT-proBNP (N-terminal pro-B-type natriuretic peptide), hs-TnI (high-sensitivity troponin I), and hs-CRP (high-sensitivity C-reactive protein), polygenic risk for lipoprotein(a) and polygenic risk for coronary artery disease, and absence of family history of ASCVD. Incident ASCVD events were adjudicated by expert panels. Statistical performance of each marker was assessed using diagnostic likelihood ratios, change in Harrell C statistic (ΔC), and net reclassification index relative to a baseline model incorporating variables included in the PREVENT equation. RESULTS: The study included 7764 participants (48% female; median age, 74 years [interquartile range, 72–77]), with a median follow-up of 10.3 years. During follow-up, 725 participants (9.3%) experienced ASCVD events. Q1 polygenic risk for coronary artery disease was the most powerful marker for down-grading risk, providing 37% risk reduction (diagnostic likelihood ratio: 0.627) and improving discrimination (ΔC: +1.44%; P =0.004) when compared with the baseline model, and correctly reclassifying 25.9% of nonevents downward (net reclassification index: 0.101). Q1 hs-TnI showed second-best performance (diagnostic likelihood ratio: 0.727; ΔC: +0.71%, net reclassification index: 0.075). CONCLUSIONS: Adding polygenic risk for coronary artery disease to the PREVENT equations may further personalize risk estimates and support clinical decision-making for older adults at intermediate risk for ASCVD events.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 2098-2107
Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke
BACKGROUND: Low-dose aspirin is no longer recommended for routine primary prevention in older adults due to bleeding risks outweighing vascular benefits. We hypothesized that an integrative polygenic score (iPGS) could identify a subgroup of older individuals who derive net benefit from aspirin for the primary prevention of ischemic stroke. METHODS: We performed post hoc analysis of the ASPREE randomized, placebo-controlled trial (Aspirin in Reducing Events in the Elderly) of daily 100-mg aspirin, in 12 031 genotyped participants of European ancestry aged >70 years without prior cardiovascular disease. The iPGS was derived from >1.2 million variants and evaluated both continuously and by quintiles. Cox models assessed associations between polygenic risk, ischemic stroke, and major bleeding events, and tested the interaction between the iPGS and treatment allocation, with adjustment for baseline lifestyle and clinical covariates. RESULTS: The mean age of participants was 75.1 years, and 54.9% were women. Over a median of 4.6 years, 187 ischemic strokes and 373 major bleeds occurred, including 101 intracranial bleeds (46 hemorrhagic strokes). Each 1-SD increase in the iPGS was associated with higher incident ischemic stroke risk (hazard ratio, 1.39 [95% CI, 1.20–1.62]). An interaction between the continuous iPGS and aspirin allocation was observed for ischemic stroke ( P =0.04) but not major bleeding. In the highest iPGS quintile, aspirin reduced ischemic stroke by 51% (hazard ratio, 0.49 [95% CI, 0.28–0.85]) without significantly increasing major bleeding (hazard ratio, 1.15 [95% CI, 0.71–1.88]). No benefit was observed in the overall cohort or in lower-risk quintiles. CONCLUSIONS: Among older adults, high polygenic risk identifies individuals who may experience substantial stroke reduction with aspirin, with no excess bleeding. These findings raise the possibility that genomic risk stratification may enable targeted aspirin use for the primary prevention of ischemic stroke. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583.
- 1 July 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (7) , 2098-2107
Polygenic Risk Identifies Older Adults Who May Benefit From Aspirin for the Primary Prevention of Ischemic Stroke
BACKGROUND: Low-dose aspirin is no longer recommended for routine primary prevention in older adults due to bleeding risks outweighing vascular benefits. We hypothesized that an integrative polygenic score (iPGS) could identify a subgroup of older individuals who derive net benefit from aspirin for the primary prevention of ischemic stroke. METHODS: We performed post hoc analysis of the ASPREE randomized, placebo-controlled trial (Aspirin in Reducing Events in the Elderly) of daily 100-mg aspirin, in 12 031 genotyped participants of European ancestry aged >70 years without prior cardiovascular disease. The iPGS was derived from >1.2 million variants and evaluated both continuously and by quintiles. Cox models assessed associations between polygenic risk, ischemic stroke, and major bleeding events, and tested the interaction between the iPGS and treatment allocation, with adjustment for baseline lifestyle and clinical covariates. RESULTS: The mean age of participants was 75.1 years, and 54.9% were women. Over a median of 4.6 years, 187 ischemic strokes and 373 major bleeds occurred, including 101 intracranial bleeds (46 hemorrhagic strokes). Each 1-SD increase in the iPGS was associated with higher incident ischemic stroke risk (hazard ratio, 1.39 [95% CI, 1.20–1.62]). An interaction between the continuous iPGS and aspirin allocation was observed for ischemic stroke ( P =0.04) but not major bleeding. In the highest iPGS quintile, aspirin reduced ischemic stroke by 51% (hazard ratio, 0.49 [95% CI, 0.28–0.85]) without significantly increasing major bleeding (hazard ratio, 1.15 [95% CI, 0.71–1.88]). No benefit was observed in the overall cohort or in lower-risk quintiles. CONCLUSIONS: Among older adults, high polygenic risk identifies individuals who may experience substantial stroke reduction with aspirin, with no excess bleeding. These findings raise the possibility that genomic risk stratification may enable targeted aspirin use for the primary prevention of ischemic stroke. REGISTRATION: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT01038583.
- Open Access
- 8 April 2026
- Published by Springer Nature in GeroScience
Sex-specific associations of low-level urinary albumin-creatinine ratio with mortality and adverse cardiac events in older adults
Albuminuria is traditionally defined using fixed urinary albumin–creatinine ratio (UACR) thresholds, although cardiovascular disease (CVD) risk has been reported to increase continuously across the UACR spectrum. Whether these associations are present in healthy older adults and differ by sex remains unclear. We examined sex-specific associations between low-level UACR, mortality, and cardiovascular outcomes in older adults with preserved kidney function. From the ASPirin in Reducing Events in the Elderly (ASPREE) study, we included 5396 males and 6305 females aged ≥ 70 years with baseline UACR and eGFR ≥ 60 mL/min/1.73 m 2 ). Sex-stratified Cox models examined associations between UACR quintiles (Q) and mortality, CVD, major adverse cardiovascular events (MACE), and stroke, using Q1 as reference. Over a median follow-up of 8.3–8.6 years, increasing UACR was associated with progressively higher risk of all-cause mortality in both sexes, despite most values being below the guideline thresholds. Mortality risk reached statistical significance for males from Q4 (HR 1.45; 95% CI 1.18–1.77) and females from Q2 (HR 1.33; 95% CI 1.04–1.71). Males also had a statistically significant increase in CVD from Q4 (HR 1.32; 95% CI 1.03–1.70) and MACE and stroke in Q5 (HR 1.61; 95% CI 1.25–2.07 and HR 1.96; 95%CI 1.38–1.78). Despite an increasing trend in females, adverse cardiovascular outcomes did not reach significance. UACR levels below guideline thresholds were associated with all-cause mortality in both sexes, with increased cardiovascular disease predominately observed in men. These findings support a continuous relationship between UACR and risk and suggest that even low-level albuminuria may have prognostic significance in healthy older adults.
- 8 April 2026
- Published by Springer Nature in GeroScience
Open AccessSex-specific associations of low-level urinary albumin-creatinine ratio with mortality and adverse cardiac events in older adults
Albuminuria is traditionally defined using fixed urinary albumin–creatinine ratio (UACR) thresholds, although cardiovascular disease (CVD) risk has been reported to increase continuously across the UACR spectrum. Whether these associations are present in healthy older adults and differ by sex remains unclear. We examined sex-specific associations between low-level UACR, mortality, and cardiovascular outcomes in older adults with preserved kidney function. From the ASPirin in Reducing Events in the Elderly (ASPREE) study, we included 5396 males and 6305 females aged ≥ 70 years with baseline UACR and eGFR ≥ 60 mL/min/1.73 m 2 ). Sex-stratified Cox models examined associations between UACR quintiles (Q) and mortality, CVD, major adverse cardiovascular events (MACE), and stroke, using Q1 as reference. Over a median follow-up of 8.3–8.6 years, increasing UACR was associated with progressively higher risk of all-cause mortality in both sexes, despite most values being below the guideline thresholds. Mortality risk reached statistical significance for males from Q4 (HR 1.45; 95% CI 1.18–1.77) and females from Q2 (HR 1.33; 95% CI 1.04–1.71). Males also had a statistically significant increase in CVD from Q4 (HR 1.32; 95% CI 1.03–1.70) and MACE and stroke in Q5 (HR 1.61; 95% CI 1.25–2.07 and HR 1.96; 95%CI 1.38–1.78). Despite an increasing trend in females, adverse cardiovascular outcomes did not reach significance. UACR levels below guideline thresholds were associated with all-cause mortality in both sexes, with increased cardiovascular disease predominately observed in men. These findings support a continuous relationship between UACR and risk and suggest that even low-level albuminuria may have prognostic significance in healthy older adults.
- Open Access
- 30 December 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (3)
Serum uric acid levels and longitudinal change in cognitive function in older adults: a sex-stratified population-based study
Background: Serum uric acid (SUA) has been linked to cognitive function, but sex-specific associations remain unclear. Biological differences in SUA levels between sexes, driven by hormonal and renal factors, highlight the importance of sex-stratified analysis. This study examined the association between SUA levels and changes in cognitive function in older adults. Methods: A total of 11 411 community-dwelling ASPirin in Reducing Events in the Elderly participants, free from dementia at baseline and with valid SUA measurements, were included. The Modified Mini-Mental State Examination (3MS), Hopkins Verbal Learning Test–Revised (HVLT-R), Symbol Digit Modalities Test, and Controlled Oral Word Association Test were used to assess cognition at baseline and over a median follow-up of 9 years. Separate linear mixed-effects regression models in males and females were fitted to assess the associations between SUA levels and change in cognitive function over time. Results: Females in the lowest SUA quintile (Q1) had significant declines in the measure of global cognition (3MS: β ±SE= −0.07 ± 0.03, p = .02) and episodic memory (HVLT-R; delayed recall: β±SE= -0.03 ± 0.01, p = .02) compared to the middle quintiles (Q2-Q4), but the highest SUA quintile (Q5) was not associated with decline. No associations were observed for executive function, verbal fluency, or psychomotor speed. In males, no significant associations between SUA levels and change in cognitive function were observed. Conclusion: Low SUA levels were linked to decline in the measure of global cognition and episodic memory among females but not males. High SUA levels were not associated with cognitive decline. Managing SUA levels within the physiological range may support cognitive health, particularly in older females.
- 30 December 2025
- Published by Oxford University Press (OUP) in The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences
- Vol. 81 (3)
Open AccessSerum uric acid levels and longitudinal change in cognitive function in older adults: a sex-stratified population-based study
Background: Serum uric acid (SUA) has been linked to cognitive function, but sex-specific associations remain unclear. Biological differences in SUA levels between sexes, driven by hormonal and renal factors, highlight the importance of sex-stratified analysis. This study examined the association between SUA levels and changes in cognitive function in older adults. Methods: A total of 11 411 community-dwelling ASPirin in Reducing Events in the Elderly participants, free from dementia at baseline and with valid SUA measurements, were included. The Modified Mini-Mental State Examination (3MS), Hopkins Verbal Learning Test–Revised (HVLT-R), Symbol Digit Modalities Test, and Controlled Oral Word Association Test were used to assess cognition at baseline and over a median follow-up of 9 years. Separate linear mixed-effects regression models in males and females were fitted to assess the associations between SUA levels and change in cognitive function over time. Results: Females in the lowest SUA quintile (Q1) had significant declines in the measure of global cognition (3MS: β ±SE= −0.07 ± 0.03, p = .02) and episodic memory (HVLT-R; delayed recall: β±SE= -0.03 ± 0.01, p = .02) compared to the middle quintiles (Q2-Q4), but the highest SUA quintile (Q5) was not associated with decline. No associations were observed for executive function, verbal fluency, or psychomotor speed. In males, no significant associations between SUA levels and change in cognitive function were observed. Conclusion: Low SUA levels were linked to decline in the measure of global cognition and episodic memory among females but not males. High SUA levels were not associated with cognitive decline. Managing SUA levels within the physiological range may support cognitive health, particularly in older females.
- 9 December 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (23) , 1621-1633
Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial
BACKGROUND: Blood pressure (BP) management in older adults is complex because of age-related physiological changes and uncertainty around ideal systolic BP (SBP) targets. Heart stress (HS), defined by age-adjusted elevation in NT-proBNP (N-terminal pro–B-type natriuretic peptide) levels, may improve cardiovascular disease (CVD) risk stratification and support more individualized BP management. METHODS: We conducted a post hoc analysis of ASPREE (Aspirin in Reducing Events in the Elderly) involving 11 941 community-dwelling older adults without CVD at enrollment (mean age, 75.1 years; 53.5% women). HS was defined by NT-proBNP ≥150 pg/mL for participants 65 to 74 years of age and ≥300 pg/mL for participants ≥75 years of age. Participants were categorized into 4 groups by hypertension and HS status. The primary outcome was total CVD events (a composite of nonfatal myocardial infarction, fatal or nonfatal stroke, coronary heart disease death, or hospitalization for heart failure). Associations between hypertension and SBP with total CVD events were examined by HS status using Cox proportional-hazards models and restricted cubic spline. SBP was evaluated categorically (P trend P non linearity =0.011). Among participants with HS, risk increased linearly with SBP ( P linear trend =0.85) and was lowest at SBP <120 mm Hg. Landmark analyses yielded generally consistent findings. CONCLUSIONS: HS is common in older adults and jointly associated with hypertension and increased CVD risk. The SBP–CVD relationship differs by HS status, suggesting a potential value of HS for guiding individualized BP management. Prospective studies are warranted to determine whether HS-guided strategies improve BP control and reduce CVD risk in older adults.
- 9 December 2025
- Published by Wolters Kluwer Health in Circulation
- Vol. 152 (23) , 1621-1633
Heart Stress and Blood Pressure Management in Older Adults: Post Hoc Analysis of the ASPREE Trial
BACKGROUND: Blood pressure (BP) management in older adults is complex because of age-related physiological changes and uncertainty around ideal systolic BP (SBP) targets. Heart stress (HS), defined by age-adjusted elevation in NT-proBNP (N-terminal pro–B-type natriuretic peptide) levels, may improve cardiovascular disease (CVD) risk stratification and support more individualized BP management. METHODS: We conducted a post hoc analysis of ASPREE (Aspirin in Reducing Events in the Elderly) involving 11 941 community-dwelling older adults without CVD at enrollment (mean age, 75.1 years; 53.5% women). HS was defined by NT-proBNP ≥150 pg/mL for participants 65 to 74 years of age and ≥300 pg/mL for participants ≥75 years of age. Participants were categorized into 4 groups by hypertension and HS status. The primary outcome was total CVD events (a composite of nonfatal myocardial infarction, fatal or nonfatal stroke, coronary heart disease death, or hospitalization for heart failure). Associations between hypertension and SBP with total CVD events were examined by HS status using Cox proportional-hazards models and restricted cubic spline. SBP was evaluated categorically (P trend P non linearity =0.011). Among participants with HS, risk increased linearly with SBP ( P linear trend =0.85) and was lowest at SBP <120 mm Hg. Landmark analyses yielded generally consistent findings. CONCLUSIONS: HS is common in older adults and jointly associated with hypertension and increased CVD risk. The SBP–CVD relationship differs by HS status, suggesting a potential value of HS for guiding individualized BP management. Prospective studies are warranted to determine whether HS-guided strategies improve BP control and reduce CVD risk in older adults.
- 22 November 2025
- Published by Taylor & Francis in Archives of Environmental & Occupational Health
- Vol. 80 (10) , 291-302
Lifetime occupation assignment and hypertension analysis in a survivor cohort of older adults
Standard codes were assigned to each of up to 3 jobs reported by 12,498 healthy Australian participants of the ASPREE Longitudinal Study of Older Persons (ALSOP) aged ≥ 70 years. Ten job categories for men (n=5444; 92.5%) and 13 for women (n=6370; 90.8%) were generated by grouping like jobs. Inter-group distinctiveness was demonstrated by education, socio-economic status, and lifestyle factors for men and women for the occupational groups. Among men, the highest odds of age-adjusted hypertension were in general managers (1.40; 95% CI 1.08, 1.81) and tradespersons (1.29; 1.05, 1.58), with associations attenuated after controlling for lifestyle factors. Among women, the highest odds of hypertension were in nurses (1.40; 95% CI 1.05, 1.87) and clerks/secretaries (1.28; 1.01, 1.62) in multivariate analysis. This analysis indicates that those who are healthy at ≥ 70 years with a healthy lifestyle may suffer minimal detriment in regard to hypertension status from lifetime occupation.
- 22 November 2025
- Published by Taylor & Francis in Archives of Environmental & Occupational Health
- Vol. 80 (10) , 291-302
Lifetime occupation assignment and hypertension analysis in a survivor cohort of older adults
Standard codes were assigned to each of up to 3 jobs reported by 12,498 healthy Australian participants of the ASPREE Longitudinal Study of Older Persons (ALSOP) aged ≥ 70 years. Ten job categories for men (n=5444; 92.5%) and 13 for women (n=6370; 90.8%) were generated by grouping like jobs. Inter-group distinctiveness was demonstrated by education, socio-economic status, and lifestyle factors for men and women for the occupational groups. Among men, the highest odds of age-adjusted hypertension were in general managers (1.40; 95% CI 1.08, 1.81) and tradespersons (1.29; 1.05, 1.58), with associations attenuated after controlling for lifestyle factors. Among women, the highest odds of hypertension were in nurses (1.40; 95% CI 1.05, 1.87) and clerks/secretaries (1.28; 1.01, 1.62) in multivariate analysis. This analysis indicates that those who are healthy at ≥ 70 years with a healthy lifestyle may suffer minimal detriment in regard to hypertension status from lifetime occupation.
- 29 October 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (4) , 1-11
Elevated alpha-1 antitrypsin and C-reactive protein: association on all-cause and cause-specific mortality in older adults
Alpha-1 antitrypsin (AAT) deficiency in younger people is well characterized, but the effects of elevated AAT levels in older age are unclear. We examined the effect of elevated AAT levels and mortality in a longitudinal cohort of older adults, alongside high-sensitivity C-reactive protein (hs-CRP) levels. This post hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) trial included 11,879 adults aged ≥ 70 years without prior cardiovascular disease, dementia or life-limiting illness at enrolment. Cox proportional hazard models estimated adjusted hazard ratios (aHRs) for all-cause and cause-specific mortality (cancer, cardiovascular and other) over a median follow-up of 10.9 years. AAT and hs-CRP were analyzed in deciles, comparing the highest decile to the middle 80% as reference. Median (IQR) levels of AAT and hs-CRP in the top decile were 1.69 (1.65–1.78) g/L and 10.40 (7.97–15.53) mg/L, respectively. Individuals in highest AAT decile had a 53% higher likelihood of mortality during follow-up (aHR 1.53, 95% CI 1.28–1.65). Risk of cancer, cardiovascular and ‘other’ deaths were all elevated. The associations remained significant after excluding participants with elevated hs-CRP. Participants in the highest hs-CRP decile had a 32% higher likelihood of mortality (aHR 1.32, 95% CI 1.18–1.48). Elevated hs-CRP was associated with cancer and ‘other’ mortality but not cardiovascular mortality. Elevated AAT is a robust predictor of mortality in older adults, independent of hs-CRP, and may reflect subtle, age-related changes in systemic inflammation. These findings support the potential utility of AAT as a biomarker of biological ageing and mortality risk.
- 29 October 2025
- Published by Springer Nature in GeroScience
- Vol. 48 (4) , 1-11
Elevated alpha-1 antitrypsin and C-reactive protein: association on all-cause and cause-specific mortality in older adults
Alpha-1 antitrypsin (AAT) deficiency in younger people is well characterized, but the effects of elevated AAT levels in older age are unclear. We examined the effect of elevated AAT levels and mortality in a longitudinal cohort of older adults, alongside high-sensitivity C-reactive protein (hs-CRP) levels. This post hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) trial included 11,879 adults aged ≥ 70 years without prior cardiovascular disease, dementia or life-limiting illness at enrolment. Cox proportional hazard models estimated adjusted hazard ratios (aHRs) for all-cause and cause-specific mortality (cancer, cardiovascular and other) over a median follow-up of 10.9 years. AAT and hs-CRP were analyzed in deciles, comparing the highest decile to the middle 80% as reference. Median (IQR) levels of AAT and hs-CRP in the top decile were 1.69 (1.65–1.78) g/L and 10.40 (7.97–15.53) mg/L, respectively. Individuals in highest AAT decile had a 53% higher likelihood of mortality during follow-up (aHR 1.53, 95% CI 1.28–1.65). Risk of cancer, cardiovascular and ‘other’ deaths were all elevated. The associations remained significant after excluding participants with elevated hs-CRP. Participants in the highest hs-CRP decile had a 32% higher likelihood of mortality (aHR 1.32, 95% CI 1.18–1.48). Elevated hs-CRP was associated with cancer and ‘other’ mortality but not cardiovascular mortality. Elevated AAT is a robust predictor of mortality in older adults, independent of hs-CRP, and may reflect subtle, age-related changes in systemic inflammation. These findings support the potential utility of AAT as a biomarker of biological ageing and mortality risk.
- Open Access
- 30 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Prevalence and outcomes of steatotic liver disease subtypes in older adults
Background: Steatotic liver disease (SLD) is a significant cause of chronic liver disease. However, the relative prevalence and prognostic significance of various disease entities according to recently defined classification systems (MAFLD vs. the SLD-spectrum of MASLD, Met-ALD, and ALD) is understudied in older adults. Methods: Post hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) study involving 16,703 Australian community-dwelling adults aged ≥70 years free from significant disability, prior cardiovascular disease events, and with a life expectancy ≥5 years. Steatosis was identified by Fatty Liver Index (FLI) ≥60. Alcohol intake was self-reported. SLD subtypes were classified according to European Association for the Study of the Liver (EASL)/American Association for the Study of Liver Diseases (AASLD) guidelines. Cox regression was used to estimate hazard ratios for adjudicated outcomes: mortality, major adverse cardiovascular events (MACE), and persistent physical disability. Results: Of 9847 participants with calculable FLI and a median 8.6 years follow-up, 3748 (38.1%) had hepatic steatosis. Substratifying by MAFLD criteria versus the SLD type, 3743 had MAFLD (38.0%), and 3464 (35.2%) met SLD criteria (MASLD 3132 [90.4%], Met-ALD 262 [7.6%], ALD 74 [2.0%]) (excluding steatogenic medication users). There was no increased mortality risk with MAFLD or SLD. MAFLD and MASLD were associated with MACE when adjusted for age and sex (HR 1.42 [95% CI 1.17–1.71] and HR 1.40 [95% CI 1.15–1.71], respectively), but not in the fully adjusted model. MAFLD, MASLD, and ALD were associated with an increased risk of persistent physical disability even when fully adjusted (HR 1.46 [95% CI 1.19–1.79], HR 1.49 [95% CI 1.20–1.83], HR 2.53 [95% CI 1.27–5.05], respectively), but not Met-ALD. Conclusions: MAFLD and the metabolic-SLD spectrum are common in community-dwelling older adults. No subclassification is associated with increased mortality in this group, although there is an association between both MACE and persistent physical disability with SLD.
- 30 June 2025
- Published by Wolters Kluwer Health in Hepatology Communications
- Vol. 9 (7)
Open AccessPrevalence and outcomes of steatotic liver disease subtypes in older adults
Background: Steatotic liver disease (SLD) is a significant cause of chronic liver disease. However, the relative prevalence and prognostic significance of various disease entities according to recently defined classification systems (MAFLD vs. the SLD-spectrum of MASLD, Met-ALD, and ALD) is understudied in older adults. Methods: Post hoc analysis of the ASPirin in Reducing Events in the Elderly (ASPREE) study involving 16,703 Australian community-dwelling adults aged ≥70 years free from significant disability, prior cardiovascular disease events, and with a life expectancy ≥5 years. Steatosis was identified by Fatty Liver Index (FLI) ≥60. Alcohol intake was self-reported. SLD subtypes were classified according to European Association for the Study of the Liver (EASL)/American Association for the Study of Liver Diseases (AASLD) guidelines. Cox regression was used to estimate hazard ratios for adjudicated outcomes: mortality, major adverse cardiovascular events (MACE), and persistent physical disability. Results: Of 9847 participants with calculable FLI and a median 8.6 years follow-up, 3748 (38.1%) had hepatic steatosis. Substratifying by MAFLD criteria versus the SLD type, 3743 had MAFLD (38.0%), and 3464 (35.2%) met SLD criteria (MASLD 3132 [90.4%], Met-ALD 262 [7.6%], ALD 74 [2.0%]) (excluding steatogenic medication users). There was no increased mortality risk with MAFLD or SLD. MAFLD and MASLD were associated with MACE when adjusted for age and sex (HR 1.42 [95% CI 1.17–1.71] and HR 1.40 [95% CI 1.15–1.71], respectively), but not in the fully adjusted model. MAFLD, MASLD, and ALD were associated with an increased risk of persistent physical disability even when fully adjusted (HR 1.46 [95% CI 1.19–1.79], HR 1.49 [95% CI 1.20–1.83], HR 2.53 [95% CI 1.27–5.05], respectively), but not Met-ALD. Conclusions: MAFLD and the metabolic-SLD spectrum are common in community-dwelling older adults. No subclassification is associated with increased mortality in this group, although there is an association between both MACE and persistent physical disability with SLD.
- Open Access
- 16 May 2025
- Published by Elsevier in Metabolism Open
- Vol. 26, 100371
Higher serum uric acid levels and risk of all-cause mortality in general population: a systematic review and meta-analysis
- 16 May 2025
- Published by Elsevier in Metabolism Open
- Vol. 26, 100371
Open AccessHigher serum uric acid levels and risk of all-cause mortality in general population: a systematic review and meta-analysis
- Open Access
Mediterranean Diet and Ultra-Processed Food Intake in Older Australian Adults—Associations with Frailty and Cardiometabolic Conditions
Dietary patterns contribute to overall health and diseases of ageing but are understudied in older adults. As such, we first aimed to develop dietary indices to quantify Mediterranean Diet Score (MDS) utilisation and Ultra-processed Food (UPF) intake in a well-characterised cohort of relatively healthy community-dwelling older Australian adults. Second, we aimed to understand the relationship between these scores and the association of these scores with prevalent cardiometabolic disease and frailty. Our major findings are that in this population of older adults, (a) pre-frailty and frailty are associated with reduced MDS and increased UPF intake; (b) adherence to MDS eating patterns does not preclude relatively high intake of UPF (and vice versa); and (c) high utilisation of an MDS eating pattern does not prevent an increased risk of frailty with higher UPF intakes. As such, the Mediterranean Diet pattern should be encouraged in older adults to potentially reduce the risk of frailty, while the impact of UPF intake should be further explored given the convenience these foods provide to a population whose access to unprocessed food may be limited due to socioeconomic, health, and lifestyle factors.
Open AccessMediterranean Diet and Ultra-Processed Food Intake in Older Australian Adults—Associations with Frailty and Cardiometabolic Conditions
Dietary patterns contribute to overall health and diseases of ageing but are understudied in older adults. As such, we first aimed to develop dietary indices to quantify Mediterranean Diet Score (MDS) utilisation and Ultra-processed Food (UPF) intake in a well-characterised cohort of relatively healthy community-dwelling older Australian adults. Second, we aimed to understand the relationship between these scores and the association of these scores with prevalent cardiometabolic disease and frailty. Our major findings are that in this population of older adults, (a) pre-frailty and frailty are associated with reduced MDS and increased UPF intake; (b) adherence to MDS eating patterns does not preclude relatively high intake of UPF (and vice versa); and (c) high utilisation of an MDS eating pattern does not prevent an increased risk of frailty with higher UPF intakes. As such, the Mediterranean Diet pattern should be encouraged in older adults to potentially reduce the risk of frailty, while the impact of UPF intake should be further explored given the convenience these foods provide to a population whose access to unprocessed food may be limited due to socioeconomic, health, and lifestyle factors.